Explore the challenges of AI integration in Indian healthcare. Learn how AI can improve diagnostics and patient...
medical devices
Lupin receives tentative USFDA approval for generic Sugammadex injection, a muscle relaxant reversal agent. Key step in...
Dr. Reddy's Laboratories secures temporary legal approval to market its semaglutide brand 'Olymviq' for 30 days. A...
NovaBay Pharmaceuticals rebrands to Stablecoin Development Corporation, signaling a shift towards blockchain and digital assets. Details on...
India's healthcare sector aims for $700 billion by 2030, facing financing and infrastructure challenges. Public-private partnerships are...
India's drug regulator increases scrutiny of GLP-1 weight loss drugs due to unauthorized sales and improper prescriptions....
Delhi's healthcare sector expands with 1,288 new hospital beds and improved emergency response. Addressing rising demand and...
Indian drugmakers launch affordable generic versions of Ozempic & Wegovy, slashing costs by 70%. Increased access to...
Indian drugmakers compete for obesity market share as generic weight-loss drugs drive prices down, increasing access but...
Alkem Labs enters India's weight-loss market with Semaglutide injection, offering a cost-effective solution for diabetes and weight...